, , vol.140, p.4, 1971.
, , 2012.
, , p.80, 2012.
, , p.12, 2011.
, , vol.72, p.26, 2003.
, , vol.2, p.19, 2009.
, , vol.606, 1995.
-Benzyloxy-4,5-dihydro-1H-imidazol-2-yl-amines, a novel class of NR1/2B subtype selective NMDA receptor antagonists, Bioorg Med Chem Lett, vol.1, pp.3155-3159, 2003. ,
Preparation of imidazole derivatives as NMDA (N-methyl-Daspartate) receptor subtype 2B selective blockers. Patent #WO, 2002. ,
Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes, Eur J Pharmacol, vol.296, pp.209-213, 1996. ,
NR2B selective NMDA antagonists: the evolution of the ifenprodil-type pharmacophore, Curr Top Med Chem, vol.6, pp.687-695, 2006. ,
) 2,6-Disubstituted pyrazines and related analogs as NR2B site antagonists of the NMDA receptor with anti-depressant activity, Bioorg Med Chem Lett, vol.21, pp.3399-3403, 2011. ,
Mapping the binding of GluN2B-selective N-methyl-Daspartate receptor negative allosteric modulators, Mol Pharmacol, vol.82, pp.344-359, 2012. ,
,4-Dihydro-1H-isoquinolin-2yl)-pyridines as a novel class of NR1/2B subtype selective NMDA receptor antagonists, Bioorg Med Chem Lett, vol.2, issue.3, pp.829-832, 2003. ,
Synthesis and pharmacological properties of a series of 2-piperidino alkanol derivatives, Arzneimittelforschung, vol.21, pp.1992-1998, 1971. ,
1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses, J Med Chem, vol.38, pp.3138-3145, 1995. ,
Antagonists selective for NMDA receptors containing the NR2B subunit, Curr Pharm Des, vol.5, pp.381-404, 1999. ,
Separation of alpha 1 adrenergic and N-methyl-Daspartate antagonist activity in a series of ifenprodil compounds, J Med Chem, vol.34, pp.3085-3090, 1991. ,
NMDA receptor antagonists as analgesics: focus on the NR2B subtype, Trends Pharmacol Sci, vol.22, pp.636-642, 2001. ,
Orally efficacious NR2B-selective NMDA receptor antagonists, Bioorg Med Chem Lett, vol.13, pp.697-700, 2003. ,
, The CCP4 suite: programs for protein crystallography, Collaborative Computational Project, Number, vol.4, pp.760-763, 1994.
A novel series of benzimidazole NR2B-selective NMDA receptor antagonists, Bioorg Med Chem Lett, vol.22, pp.2620-2623, 2012. ,
POVME: an algorithm for measuring binding-pocket volumes, J Mol Graph Model, vol.29, pp.773-776, 2011. ,
Ro 25-6981, a highly potent and selective blocker of N-methyl-Daspartate receptors containing the NR2B subunit. Characterization in vitro, J Pharmacol Exp Ther, vol.283, pp.1285-1292, 1997. ,
Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy, J Med Chem, vol.47, pp.1739-1749, 2004. ,
Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes, J Med Chem, vol.49, pp.6177-6196, 2006. ,
Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor, J Biol Chem, vol.271, pp.9603-9611, 1996. ,
Synthesis and biological characterization of 3-substituted 1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors. Part 2, J Med Chem, vol.55, pp.10532-10539, 2012. ,
SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling, Electrophoresis, vol.18, pp.2714-2723, 1997. ,
Jr (2012) A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder, J Clin Psychopharmacol, vol.32, pp.551-557 ,
NMDA receptors in clinical neurology: excitatory times ahead, Lancet Neurol, vol.7, pp.742-755, 2008. ,
Crystal structure of a heterotetrameric NMDA receptor ion channel, Science, vol.344, pp.992-997, 2014. ,
Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit, EMBO J, vol.28, pp.3910-3920, 2009. ,
Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors, Nature, vol.475, pp.249-253, 2011. ,
Methods for treating disorders using NMDA NR2B-subtype selective antagonist, Patent #WO 2009118187A1. Applicant: Evotec Neurosciences Gmbh, 2009. ,
A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones, J Physiol, vol.497, pp.761-772, 1996. ,
Preparation of substituted oxadiazoles and related compounds as selective NR2B antagonists. Patent #WO, 2012. ,
Recent advances in the development of NR2B subtype-selective NMDA receptor antagonists, Curr Top Med Chem, vol.6, pp.697-709, 2006. ,
Discovery of 3-substituted aminocyclopentanes as potent and orally bioavailable NR2B subtypeselective NMDA antagonists, ACS Chem Neurosci, vol.2, pp.352-362, 2011. ,
NMDA receptor structures reveal subunit arrangement and pore architecture, Nature, vol.511, pp.191-197, 2014. ,
) inventors, Merck Sharp & Dohme Corp, assignees. 3-Fluoro-piperidines as NMDA/NR2B antagonists, 2004. ,
Identification of critical residues in the amino terminal domain of the human NR2B subunit involved in the RO 25-6981 binding pocket, J Pharmacol Exp Ther, vol.307, pp.897-905, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-00139990
The subtype of GluN2 C-terminal domain determines the response to excitotoxic insults, Neuron, vol.74, pp.543-556, 2012. ,
A regulatory domain (R1-R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein, Mol Pharmacol, vol.55, pp.957-969, 1999. ,
Synthesis and evaluation of novel tricyclic benzo, Bioorg Med Chem Lett, vol.19, pp.5132-5135, 2009. ,
New and original pKa prediction method using grid molecular interaction fields, J Chem Inf Model, vol.47, pp.2172-2181, 2007. ,
Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential, Br J Pharmacol, vol.157, pp.1301-1317, 2009. ,
Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors, Mol Pharmacol, vol.75, pp.60-74, 2009. ,
Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines, EMBO J, vol.30, pp.3134-3146, 2011. ,
Developmental and regional expression in the rat brain and functional properties of four NMDA receptors, Neuron, vol.12, pp.529-540, 1994. ,
Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition, Nat Neurosci, vol.1, pp.659-667, 1998. ,
NR2B selective NMDA receptor antagonists, Curr Pharm Des, vol.8, pp.845-855, 2002. ,
Molecular basis of NMDA receptor functional diversity, Eur J Neurosci, vol.33, pp.1351-1365, 2011. ,
High-affinity zinc inhibition of NMDA NR1-NR2A receptors, J Neurosci, vol.17, pp.5711-5725, 1997. ,
URL : https://hal.archives-ouvertes.fr/hal-00139995
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease, Nat Rev Neurosci, vol.14, pp.383-400, 2013. ,
Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors, J Neurosci, vol.22, pp.5955-5965, 2002. ,
URL : https://hal.archives-ouvertes.fr/hal-00115555
An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder, J Clin Psychopharmacol, vol.28, pp.631-637, 2008. ,
Comparison of Automatic Three-Dimensional Model Builders Using 639 X-Ray Structures, J Chem Inf Comput Sci, vol.34, pp.1000-1008, 1994. ,
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments, J Comput Aided Mol Des, vol.27, pp.221-234, 2013. ,
Measurement of dissociation constants (pKa values) of organic compounds by multiplexed capillary electrophoresis using aqueous and cosolvent buffers, J Pharm Sci, vol.97, pp.2581-2606, 2008. ,
Changing subunit composition of heteromeric NMDA receptors during development of rat cortex, Nature, vol.368, pp.144-147, 1994. ,
In vitro and antinociceptive profile of HON0001, an orally active NMDA receptor NR2B subunit antagonist, Pharmacol Biochem Behav, vol.84, pp.134-141, 2006. ,
Enantiomerically pure 2-methyltetrahydro-3-benzazepin-1-ols selectively blocking GluN2B subunit containing N-methyl-D-aspartate receptors, J Med Chem, vol.58, pp.6293-6305, 2015. ,
Glutamate receptor ion channels: structure, regulation, and function, Pharmacol Rev, vol.62, pp.405-496, 2010. ,
Data processing and analysis with the autoPROC toolbox, Acta Crystallogr D Biol Crystallogr, vol.67, pp.293-302, 2011. ,
Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors, Mol Pharmacol, vol.44, pp.851-859, 1993. ,
Context-dependent GluN2B-selective inhibitors of NMDA receptor function are neuroprotective with minimal side effects, Neuron, vol.85, pp.1305-1318, 2015. ,
Allosteric modulators of NMDA receptors: multiple sites and mechanisms, Curr Opin Pharmacol, vol.20, pp.14-23, 2015. ,
Genetically encoding a light switch in an ionotropic glutamate receptor reveals subunit-specific interfaces, Proc Natl Acad Sci, vol.111, pp.6081-6086, 2014. ,
Allosteric signaling and dynamics of the clamshell-like NMDA receptor GluN1 N-terminal domain, Nat Struct Mol Biol, vol.20, pp.477-485, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01498074